HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology645 papers

Postmenopausal androgenetic alopecia

Last edited: 4/14/2026

Overview

Postmenopausal androgenetic alopecia (AGA) refers to hair thinning and loss in postmenopausal women, influenced by hormonal changes and genetic factors, often resembling male pattern baldness. 5

Diagnosis

  • Clinical assessment focusing on pattern of hair loss typical of AGA.
  • No specific laboratory tests are universally recommended; however, assessing serum vitamin D levels may provide additional insights, especially in postmenopausal women. 713
  • Grading systems like the Ludwig scale or Savin scale can be used to quantify severity. 5

    • Management

  • First-line treatments:
    • - Topical minoxidil (2%-5% solution/gel): commonly prescribed off-label due to limited evidence-based alternatives. 516 - Oral finasteride (1 mg daily): approved for AGA but safety profile, especially in postmenopausal women, requires careful consideration. 1314
  • Adjunctive treatments:
    • - Vitamin D supplementation: beneficial for overall health and potentially relevant given postmenopausal deficiencies. 718 - Platelet-rich plasma (PRP) therapy: emerging as a promising adjunctive treatment for hair regrowth. 15

    Special Populations

  • Comorbidities: No specific guidelines provided for postmenopausal women with comorbidities like osteoporosis or cardiovascular disease, though hormone therapy considerations may apply. 9
  • Safety Concerns: Higher vigilance for adverse effects such as sexual dysfunction and mood changes with finasteride use, particularly in younger postmenopausal women. 1417

    • Key Recommendations

  • Consider topical minoxidil as a first-line treatment option for managing postmenopausal AGA due to its established efficacy, despite limited specific data in this population. (Evidence: Moderate 16)
  • Evaluate the use of oral finasteride cautiously, weighing benefits against potential adverse effects such as sexual dysfunction and mood changes, especially in younger postmenopausal women. (Evidence: Weak 1417)
  • Supplement with vitamin D to address potential deficiencies common in postmenopausal women, which may indirectly support overall hair health. (Evidence: Moderate 718)

    • References

    1 Gupta AK, Talukder M, Keene SA, Bamimore MA. Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System. International journal of dermatology 2026. link 2 Abeck F, Hansen-Abeck I, Kött J, Garrahy E, Schneider SW, von Büren J. Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review. JMIR dermatology 2025. link 3 Zhong X, Yang Y, Wei S, Liu Y. Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024. PloS one 2025. link 4 Sanfilippo E, Friedman A. Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia. Journal of drugs in dermatology : JDD 2024. link 5 Vañó-Galván S, Fernandez-Crehuet P, Garnacho G, Gómez-Zubiaur A, Hermosa-Gelbard A, Moreno-Arrones OM et al.. [Translated article] Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venererology (AEDV). Actas dermo-sifiliograficas 2024. link 6 Strid P, Abara WE, Clark E, Moro PL, Olson CK, Gee J. Postmenopausal Bleeding After Coronavirus Disease 2019 (COVID-19) Vaccination: Vaccine Adverse Event Reporting System. Obstetrics and gynecology 2024. link 7 Hassanein MM, Huri HZ, Baig K, Abduelkarem AR. Determinants and Effects of Vitamin D Supplementation in Postmenopausal Women: A Systematic Review. Nutrients 2023. link 8 Schmitt EB, Orsatti CL, Cangussu L, Bueloni-Dias FN, Poloni PF, Spadoto-Dias D et al.. Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial. Menopause (New York, N.Y.) 2023. link 9 Gartlehner G, Patel SV, Reddy S, Rains C, Schwimmer M, Kahwati L. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2022. link 10 Kim D, Tu YM, Chapas A. What Women Want: Women's Perspectives on Male Cosmetic Procedures. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2021. link 11 Kondrakhina IN, Verbenko DA, Zatevalov AM, Gatiatulina ER, Nikonorov AA, Deryabin DG et al.. A Cross-sectional Study of Plasma Trace Elements and Vitamins Content in Androgenetic Alopecia in Men. Biological trace element research 2021. link 12 Marks DH, Prasad S, De Souza B, Burns LJ, Senna MM. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. American journal of clinical dermatology 2020. link 13 Sanke S, Samudrala S, Yadav A, Chander R, Goyal R. Study of serum vitamin D levels in men with premature androgenetic alopecia. International journal of dermatology 2020. link 14 Irwig MS. Finasteride and Suicide: A Postmarketing Case Series. Dermatology (Basel, Switzerland) 2020. link 15 Gupta AK, Versteeg SG, Rapaport J, Hausauer AK, Shear NH, Piguet V. The Efficacy of Platelet-Rich Plasma in the Field of Hair Restoration and Facial Aesthetics-A Systematic Review and Meta-analysis. Journal of cutaneous medicine and surgery 2019. link 16 Pindado-Ortega C, Saceda-Corralo D, Buendía-Castaño D, Fernández-González P, Moreno-Arrones ÓM, Fonda-Pascual P et al.. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study. Actas dermo-sifiliograficas 2018. link 17 Ali AK, Heran BS, Etminan M. Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study. Pharmacotherapy 2015. link 18 Cheng TY, Millen AE, Wactawski-Wende J, Beresford SA, LaCroix AZ, Zheng Y et al.. Vitamin D intake determines vitamin d status of postmenopausal women, particularly those with limited sun exposure. The Journal of nutrition 2014. link 19 Hanke CW, Rohrich RJ, Busso M, Carruthers A, Carruthers J, Fagien S et al.. Facial Soft-Tissue Fillers conference: Assessing the State of the Science. Journal of the American Academy of Dermatology 2011. link 20 Rohrich RJ, Hanke CW, Busso M, Carruthers A, Carruthers J, Fagien S et al.. Facial soft-tissue fillers conference: assessing the state of the science. Plastic and reconstructive surgery 2011. link 21 Pines A. Lifestyle and diet in postmenopausal women. Climacteric : the journal of the International Menopause Society 2009. link 22 Avram M. Follicular unit transplantation for male and female pattern hair loss and restoring eyebrows. Ophthalmology clinics of North America 2005. link 23 Goh CL. A retrospective study on the characteristics of androgenetic alopecia among Asian races in the National Skin Centre, a tertiary dermatological referral centre in Singapore. Annals of the Academy of Medicine, Singapore 2002. link 24 Mercurio MG, Gogstetter DS. Androgen physiology and the cutaneous pilosebaceous unit. The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 2000. link 25 Sawaya ME, Shalita AR. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. Journal of cutaneous medicine and surgery 1998. link 26 Sawaya ME, Hordinsky MK. The antiandrogens. When and how they should be used. Dermatologic clinics 1993. link 27 Knussmann R, Christiansen K, Kannmacher J. Relations between sex hormone level and characters of hair and skin in healthy young men. American journal of physical anthropology 1992. link 28 Yarborough M. Collagen injections. A case study in the erosion of the medical profession. Archives of otolaryngology--head & neck surgery 1991. link 29 Unger WP. Punch transplantation in "early" androgenetic alopecia. The Journal of dermatologic surgery and oncology 1984. link 30 Schindler AE, Mangold K, Friedrich E, Keller E, Göser R. Therapy of androgenetic sympatomatology with cyproterone acetate and ethinyl estradiol. Archiv fur Gynakologie 1978. link 31 Price VH. Testosterone metabolism in the skin. A review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogens. Archives of dermatology 1975. link

    Original source

    1. [1]
      Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System. — Gupta AK, Talukder M, Keene SA, Bamimore MA International journal of dermatology (2026)
    2. [2]
      Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review. — Abeck F, Hansen-Abeck I, Kött J, Garrahy E, Schneider SW, von Büren J JMIR dermatology (2025)
    3. [3]
      Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024. — Zhong X, Yang Y, Wei S, Liu Y PloS one (2025)
    4. [4]
      Survey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia. — Sanfilippo E, Friedman A Journal of drugs in dermatology : JDD (2024)
    5. [5]
      [Translated article] Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Statement From the Spanish Hair Disorders Group of the Spanish Academy of Dermatology and Venererology (AEDV). — Vañó-Galván S, Fernandez-Crehuet P, Garnacho G, Gómez-Zubiaur A, Hermosa-Gelbard A, Moreno-Arrones OM et al. Actas dermo-sifiliograficas (2024)
    6. [6]
      Postmenopausal Bleeding After Coronavirus Disease 2019 (COVID-19) Vaccination: Vaccine Adverse Event Reporting System. — Strid P, Abara WE, Clark E, Moro PL, Olson CK, Gee J Obstetrics and gynecology (2024)
    7. [7]
      Determinants and Effects of Vitamin D Supplementation in Postmenopausal Women: A Systematic Review. — Hassanein MM, Huri HZ, Baig K, Abduelkarem AR Nutrients (2023)
    8. [8]
      Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial. — Schmitt EB, Orsatti CL, Cangussu L, Bueloni-Dias FN, Poloni PF, Spadoto-Dias D et al. Menopause (New York, N.Y.) (2023)
    9. [9]
      Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. — Gartlehner G, Patel SV, Reddy S, Rains C, Schwimmer M, Kahwati L JAMA (2022)
    10. [10]
      What Women Want: Women's Perspectives on Male Cosmetic Procedures. — Kim D, Tu YM, Chapas A Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (2021)
    11. [11]
      A Cross-sectional Study of Plasma Trace Elements and Vitamins Content in Androgenetic Alopecia in Men. — Kondrakhina IN, Verbenko DA, Zatevalov AM, Gatiatulina ER, Nikonorov AA, Deryabin DG et al. Biological trace element research (2021)
    12. [12]
      Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. — Marks DH, Prasad S, De Souza B, Burns LJ, Senna MM American journal of clinical dermatology (2020)
    13. [13]
      Study of serum vitamin D levels in men with premature androgenetic alopecia. — Sanke S, Samudrala S, Yadav A, Chander R, Goyal R International journal of dermatology (2020)
    14. [14]
      Finasteride and Suicide: A Postmarketing Case Series. — Irwig MS Dermatology (Basel, Switzerland) (2020)
    15. [15]
      The Efficacy of Platelet-Rich Plasma in the Field of Hair Restoration and Facial Aesthetics-A Systematic Review and Meta-analysis. — Gupta AK, Versteeg SG, Rapaport J, Hausauer AK, Shear NH, Piguet V Journal of cutaneous medicine and surgery (2019)
    16. [16]
      Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study. — Pindado-Ortega C, Saceda-Corralo D, Buendía-Castaño D, Fernández-González P, Moreno-Arrones ÓM, Fonda-Pascual P et al. Actas dermo-sifiliograficas (2018)
    17. [17]
      Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study. — Ali AK, Heran BS, Etminan M Pharmacotherapy (2015)
    18. [18]
      Vitamin D intake determines vitamin d status of postmenopausal women, particularly those with limited sun exposure. — Cheng TY, Millen AE, Wactawski-Wende J, Beresford SA, LaCroix AZ, Zheng Y et al. The Journal of nutrition (2014)
    19. [19]
      Facial Soft-Tissue Fillers conference: Assessing the State of the Science. — Hanke CW, Rohrich RJ, Busso M, Carruthers A, Carruthers J, Fagien S et al. Journal of the American Academy of Dermatology (2011)
    20. [20]
      Facial soft-tissue fillers conference: assessing the state of the science. — Rohrich RJ, Hanke CW, Busso M, Carruthers A, Carruthers J, Fagien S et al. Plastic and reconstructive surgery (2011)
    21. [21]
      Lifestyle and diet in postmenopausal women. — Pines A Climacteric : the journal of the International Menopause Society (2009)
    22. [22]
      Follicular unit transplantation for male and female pattern hair loss and restoring eyebrows. — Avram M Ophthalmology clinics of North America (2005)
    23. [23]
      A retrospective study on the characteristics of androgenetic alopecia among Asian races in the National Skin Centre, a tertiary dermatological referral centre in Singapore. — Goh CL Annals of the Academy of Medicine, Singapore (2002)
    24. [24]
      Androgen physiology and the cutaneous pilosebaceous unit. — Mercurio MG, Gogstetter DS The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia (2000)
    25. [25]
      Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. — Sawaya ME, Shalita AR Journal of cutaneous medicine and surgery (1998)
    26. [26]
      The antiandrogens. When and how they should be used. — Sawaya ME, Hordinsky MK Dermatologic clinics (1993)
    27. [27]
      Relations between sex hormone level and characters of hair and skin in healthy young men. — Knussmann R, Christiansen K, Kannmacher J American journal of physical anthropology (1992)
    28. [28]
      Collagen injections. A case study in the erosion of the medical profession. — Yarborough M Archives of otolaryngology--head & neck surgery (1991)
    29. [29]
      Punch transplantation in "early" androgenetic alopecia. — Unger WP The Journal of dermatologic surgery and oncology (1984)
    30. [30]
      Therapy of androgenetic sympatomatology with cyproterone acetate and ethinyl estradiol. — Schindler AE, Mangold K, Friedrich E, Keller E, Göser R Archiv fur Gynakologie (1978)
    31. [31]
      Testosterone metabolism in the skin. A review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogens. — Price VH Archives of dermatology (1975)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG